Interestingly, increased in vivo expression of TLR3 and TLR4 have been identified in MS brain and spinal cord sections in comparison to controls, as shown by immunohistochemical analysis (Bsibsi et al., 2002). This evidence concerns the gene TLR4 and myeloid sarcoma.